Guest Host: Steve Roberts

Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.

Guests

  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, May 01 2015Japan's prime minister urges Congress to support the TPP trade pact. Saudi Arabia's king redraws the line of succession. And the death count in Nepal's earthquake surpasses 6,000. A panel of journalists joins guest host Susan Page for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, May 01 2015Baltimore Police turn over Freddie Gray's death report to the Maryland state prosecutor but not to the public. The Supreme Court hears arguments on same-sex marriage and lethal injections. And Bernie Sanders says he'll run for president as a Democrat. A panel of journalists joins guest host Susan Page for analysis of the week's top national news stories.

The Pros And Cons Of Waste-to-Energy Incinerators

Thursday, Apr 30 2015Waste-to-energy incinerators burn garbage to generate electricity. Communities often oppose them because of pollution concerns. But some cities and counties are reconsidering them as a greener alternative to landfills. A look at the pros and cons of waste-to-energy facilities.